Synthetic Opioid key responses
- Mapping evidence-based key responses to synthetic opioids and their implementation strategies
- Field-tested Toolkit with seven implementation guides
University of Liverpool HCV Medication Interaction Website
Website database to check HCV medication interactions with other drugs
Monitoring of HCV testing in low threshold drug services - Heike Zurhold
This report documents monitoring aimed at collecting data on the proportion of drug users who have been tested for HCV, the prevalence of HCV and the number of drug users that should be tested for hepatitis C.
Monitoring the responses tohepatitis B and C epidemicsin the EU/EEA Member States2019
ECDC TECHNICAL REPORT
Beyond clinical outcomes: the social andhealthcare system implications of hepatitisC treatment
Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured.However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim ofthis research was to understand the non-clinical impact that HCV treatment has in PWID and their reasons foraccessing and completing treatment.
Improving testing rates for blood-borne viruses in prisons and other secure settings
Since 2014, Public Health England (PHE) Health and Justice has been supporting HM Prison & Probation Service (previously the National Offender Management Service) and National Health Services (NHS) England in the delivery of opt-out testing for blood-borne viruses (BBV) in all adult prisons in England. The evaluations include specific reports of offer and uptake of HIV, hepatitis B and hepatitis C testing within 72 hours of reception to prison as well as referral for treatment for those found infected. These data show that in England in 2016/17, 16 321 tests were conducted for hepatitis B infection, 21 268 for hepatitis C infection and 37 474 for HIV infection. The proportion of new receptions receiving tests for HCV increased from 5.3% in 2010/2011 to 11.5% in 2015/2016.
Training manual on HIV and HCV Rapid Testing in low threshold settings for PWUD
This training manual was developed within the EU-funded programme, Joint Action on HIV, Viral Hepatitis and Tuberculosis among People Who Inject Drugs in Europe (HA-REACT). The manual is designed to be a complete tool to provide staff in low-threshold settings the knowledge, skills and techniques needed for testing people who use drugs for HIV and HCV and linking them to needed care.
The content of the manual was adopted from previously developed guidelines, manuals and handbooks and is based on international best practices. The curriculum includes eight modules with descriptions of content to be taught and tips for practical exercises. The modules can be used as a complete 3-day training or independently.
